The 2025 KALC International Conference (KALC-IC 2025) took place on November 6–7, 2025, at the Lotte Hotel World in Seoul, Korea, organized by the Korean Association for Lung Cancer (KALC). The event brought together leading clinicians, researchers, and experts in thoracic oncology from around the world to exchange the latest knowledge and advancements in lung cancer research and treatment.
Held under the theme “Innovate, Collaborate, and Progress Against Lung Cancer,” the conference served as a vibrant platform for academic exchange and international collaboration. Over two days, participants engaged in plenary sessions, invited lectures, and e-poster presentations that highlighted cutting-edge scientific progress and emerging clinical practices in the fight against lung cancer.
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared some key highlights from the 2025 KALC International Conference:
“Brilliant session on ADCs at the KALC2025 meeting, which I was lucky to chair. Excellent talks from Drs. L. Molly & S. Saw, and a superb comprehensive overview from Peters Solange on the key points and ICIs. Always a pleasure catching up and exchanging with my Asian colleagues.”
A fantastic moment at KALC2025
“United from around the world by our passion for thoracic oncology. A fantastic moment with friends and colleagues at KALC2025.
Immense gratitude to the inspiring Prof. Myung-Ju Ahn for her leaderships and for bringing us together. Can’t wait WCLC2026.”
What a way to close out a fantastic KALC2025
“What a way to close out a fantastic KALC2025 international conference on Lung Cancer! Thank you to all our Asian colleagues for the stimulating scientific exchanges and presentations. Looking forward to seeing everyone again in Seoul for WCLC2026.”
More posts featuring David Planchard.
